There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a “cure” should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.
The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and join us.
“We believe this technology has significant potential to be considered a ‘cure’ for type 1 diabetes.”
—The authors of Targeting a Cure for Type 1 Diabetes
April 15, 2013
Over the weekend, Hanuman Medical Foundation received a very generous matching grant of $50,000 to encourage community-based funding for the Islet Sheet Project. This means Hanuman will begin an... READ MORE
October 19, 2012
At the 48th annual meeting of the EASD in Berlin, the Islet Sheet Project team presented the first data from its current study of the Islet Sheet in diabetic pigs at UC Irvine. READ MORE
ASK AN EXPERT
Have a question about diabetes research, especially about islet transplantation? Looking for sound advice about managing type 1 diabetes? Interested in the work of our foundation? Ask here, and an expert from the Hanuman team will respond.
There already are several large foundations that focus on a cure for type 1 diabetes—for example, JDRF and DRI. Why create another nonprofit foundation that can only siphon off some of the scarce contributions for very expensive research?
That’s a key question, Michael. Hanuman Medical Foundation was created to fund essential research to test a particular modality of therapy for type 1 diabetes: the use of an alginate sheet to encapsulate living islet cells, implanted in patients with... READ MORE
This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments. Click the icon below for Scott's Twitter feed.
May 16th, 2013
It’s been months since I took family leave from writing The Sheet. I have much to report on the Islet Sheet Project. For the balance of 2013 we will engage in some focused, small-scale studies to address problems identified in the pig studies. More on that very soon. Here are some other developments that I’ll... READ MORE
May 10th, 2013
by John D. Golenski Executive Director, Hanuman Medical Foundation I have good and bad news to share with readers of The Sheet. First the bad: Scott King’s sister, Debby King Mustard, who was diagnosed last December with inoperable brain cancer, passed away peacefully Sunday morning. Scott and other family members were with her. The... READ MORE
Animated views of how the Islet Sheet with its encapsulated islets works